Market Overview

UPDATE: Barrington Reiterates Outperform Rating, $650 PT on Intuitive Surgical

Related ISRG
5 Stocks With Robust Prospects, Fed Or No Fed
Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff

In a report published Friday, Barrington reiterated its Outperform rating and $650.00 price target on Intuitive Surgical (NASDAQ: ISRG).

Barrington noted, “We are reiterating our OUTPERFORM rating and $650 price target following ISRG's Q4/12 earnings as we believe management will continue to execute on its significant market opportunities over the short and long term and will drive strong procedure growth/pricing power with new technologies in new procedures. We believe the short reports circulated recently are largely based on unfounded concerns and we expect the patient and hospital demand for da Vinci procedures to remain high in the face of the issues highlighted in those reports.”

Intuitive Surgical closed on Thursday at $576.07.

Latest Ratings for ISRG

Jul 2015Canaccord GenuityUpgradesBuy
Jul 2015BarclaysMaintainsOverweight
Jul 2015Morgan StanleyDowngradesEqual-weightUnderweight

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: BarringtonAnalyst Color Reiteration Analyst Ratings


Related Articles (ISRG)

Get Benzinga's Newsletters